<html><head><link rel="stylesheet" type="text/css" href="usc.css"/><title>U.S.C. Title 21 - FOOD AND DRUGS</title></head><body>
<span style="font-weight:bold;font-size:12pt;">21 U.S.C. </span><br/>
<span style="font-size:10pt">United States Code, 2004 Edition</span><br/>
<span style="font-size:10pt">Title 21 - FOOD AND DRUGS</span><br/>
<span style="font-size:10pt">CHAPTER 9 - FEDERAL FOOD, DRUG, AND COSMETIC ACT</span><br/>
<span style="font-size:10pt">SUBCHAPTER V - DRUGS AND DEVICES</span><br/>
<span style="font-size:10pt">Part D - Dissemination of Treatment Information</span><br/>
<span style="font-size:10pt">Sec. 360aaa-6 - Rules of construction</span><br/>
<span style="font-size:10pt">From the U.S. Government Printing Office, <a href="http://www.gpo.gov">www.gpo.gov</a></span><br/><br/>
<!-- documentid:21_360aaa-6  usckey:2100000000360000000000aaa00060000 currentthrough:20050103 documentPDFPage:242 -->
<!-- itempath:/210/CHAPTER 9/SUBCHAPTER V/Part D/Sec. 360aaa-6 -->
<!-- itemsortkey:210AAIK -->
<!-- expcite:TITLE 21-FOOD AND DRUGS!@!CHAPTER 9-FEDERAL FOOD, DRUG, AND COSMETIC ACT!@!SUBCHAPTER V-DRUGS AND DEVICES!@!Part D-Dissemination of Treatment Information!@!Sec. 360aaa-6 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;360aaa&ndash;6. Rules of construction</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) Unsolicited request</h4>
<p class="statutory-body">Nothing in section 360aaa of this title shall be construed as prohibiting a manufacturer from disseminating information in response to an unsolicited request from a health care practitioner.</p>
<h4 class="subsection-head">(b) Dissemination of information on drugs or devices not evidence of intended use</h4>
<p class="statutory-body">Notwithstanding subsection (a), (f), or (<em>o</em>) of section 352 of this title, or any other provision of law, the dissemination of information relating to a new use of a drug or device, in accordance with section 360aaa of this title, shall not be construed by the Secretary as evidence of a new intended use of the drug or device that is different from the intended use of the drug or device set forth in the official labeling of the drug or device. Such dissemination shall not be considered by the Secretary as labeling, adulteration, or misbranding of the drug or device.</p>
<h4 class="subsection-head">(c) Patent protection</h4>
<p class="statutory-body">Nothing in section 360aaa of this title shall affect patent rights in any manner.</p>
<h4 class="subsection-head">(d) Authorization for dissemination of articles and fees for reprints of articles</h4>
<p class="statutory-body">Nothing in section 360aaa of this title shall be construed as prohibiting an entity that publishes a scientific journal (as defined in section 360aaa&ndash;5(5) of this title) from requiring authorization from the entity to disseminate an article published by such entity or charging fees for the purchase of reprints of published articles from such entity.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(June 25, 1938, ch. 675, &sect;557, as added Pub. L. 105&ndash;115, title IV, &sect;401(a), Nov. 21, 1997, 111 Stat. 2363.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:futureamendment-note -->
<h4 class="futureamend-note-head">Termination of Section</h4>
<p class="futureamend-note-body">For termination of section by section 401(e) of Pub. L. 105&ndash;115, see Effective and Termination Dates note set out under section 360aaa of this title.</p>
<!-- field-end:futureamendment-note -->
<!-- field-end:notes -->


</body></html>